Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis.

Taro KishiToshikazu IkutaYuki MatsudaKenji SakumaNakao Iwata

Published in: Psychopharmacology (2020)

Differences in short-term efficacy and safety for acute schizophrenia were not apparent between aripiprazole and brexpiprazole. Future studies are warranted to evaluate whether there are differences in the long-term outcome between treatments.

Keyphrases

bipolar disorder
major depressive disorder
liver failure
respiratory failure
drug induced
hepatitis b virus
magnetic resonance imaging
current status
computed tomography
diffusion weighted imaging
case control